Seventeen organizations, including the AHA, today urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors. The legislation closes the Medicare Part D coverage gap or “doughnut hole” one year earlier and requires higher drug manufacturer discounts on brand name prescription drugs while enrollees are in the coverage gap.

 

“Now, rather than build off the progress Congress has made to lower out-of-pocket costs, brand-name drug manufacturers are continuing to actively work to reverse this change at the expense of patients and taxpayers by reducing the manufacturer discount from 70 to 63 percent,” the organizations said in a letter to congressional leaders. “Moving forward with such a proposal during the lame duck session would dramatically increase costs for seniors and taxpayers, who will be forced to subsidize what amounts to a multi-billion-dollar bailout for the price-gouging pharmaceutical industry.”

 

The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, also launched an ad campaign today calling on Congress to keep its commitment to lower drug prices.

Related News Articles

Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…
Headline
The Campaign for Sustainable Rx Pricing today launched an ad campaign calling for Congress to pass bipartisan legislation to “hold Big Pharma accountable…